Exact Mass: 385.1597

Exact Mass Matches: 385.1597

Found 500 metabolites which its exact mass value is equals to given mass value 385.1597, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Polycarpine

(1Z)-1-[(2-hydroxy-3,4-dimethoxyphenyl)methylidene]-6,7-dimethoxy-3,4-dihydroisoquinoline-2-carbaldehyde

C21H23NO6 (385.1525)

O-methylandrocymbine

(1R,10S)-3,4,5,14-tetramethoxy-18-methyl-18-azatetracyclo[8.5.3.01,11.02,7]octadeca-2,4,6,11,14-pentaen-13-one

C22H27NO5 (385.1889)

O-Methylandrocymbine is an isoquinoline alkaloid. O-methylandrocymbine has been reported in Colchicum ritchii, Colchicum schimperi, and Colchicum szovitsii

Kreysigine

C22H27NO5 (385.1889)

Nocardicin G

C19H19N3O6 (385.1274)

A monobactam obtained by formal condensation of the carboxy group of (2R)-amino(4-hydroxyphenyl)acetic acid with the amino group of (2R)-[(3S)-3-amino-2-oxoazetidin-1-yl](4-hydroxyphenyl)acetic acid

Tepoxalin

3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl]-N-hydroxy-N-methylpropanamide

C20H20ClN3O3 (385.1193)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile[1].

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-{4-[methyl(nitroso)amino]-1-(pyridin-3-yl)butoxy}oxane-2-carboxylic acid

C16H23N3O8 (385.1485)

This compound belongs to the family of O-Glucuronides. These are O-Glucuronides. Glucuronides in which the aglycone is linked to the carbohydrate unit through a o-glycosidic bond.

NNAL-N-glucuronide

C16H23N3O8 (385.1485)

Gloriosine

Formamide,N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]-

C21H23NO6 (385.1525)

Vernakalant hydrochloride

Vernakalant (Hydrochloride)

C20H32ClNO4 (385.202)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C93038 - Cation Channel Blocker

Prifinium Bromide

C22H28N. Br (385.1405)

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent Same as: D01377

Sarafloxacin

6-fluoro-1-(4-Fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 9ci

C20H17F2N3O3 (385.1238)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Sarafloxacin is used for control of Campylobacter infections in poultr It is used for control of Campylobacter infections in poultry

N-Methylporphyroxine

11,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14,16,18-hexaen-16-ol

C21H23NO6 (385.1525)

N-Methylporphyroxine is an alkaloid from Papaver somniferum (opium poppy

Papaverrubine B

11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14,16,18-hexaene

C21H23NO6 (385.1525)

Papaverrubine B is found in opium poppy. Papaverrubine B is an alkaloid from Papaver rhoeas (corn poppy

Niazicin

(2S,3R,4S,5R,6S)-4,5-Dihydroxy-6-[4-({[methoxy(sulphanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetic acid

C17H23NO7S (385.1195)

Niazicin is a glucosinolate and a naturally occurring thiocarbamate. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers of niazicin (niazicin A and niazicin B, respectively) differ in the orientation of the NH group with respect to sulfur. Constituent of Moringa oleifera (horseradish tree). Niazicin A is found in fats and oils, herbs and spices, and green vegetables.

Glaucamine

16,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14,16,18-hexaen-11-ol

C21H23NO6 (385.1525)

Glaucamine is an alkaloid from Papaver rhoeas (corn poppy

Thalicpureine

2,3,4,6,7-Pentamethoxy-N-methyl-1-phenanthrenemethanamine, 9ci

C22H27NO5 (385.1889)

Thalicpureine is found in beverages. Thalicpureine is an alkaloid from the leaves of Annona purpurea (soncoya). Alkaloid from the leaves of Annona purpurea (soncoya). Thalicpureine is found in beverages and fruits.

Romucosine H

Methyl 3-hydroxy-4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaene-10-carboxylic acid

C21H23NO6 (385.1525)

Romucosine H is found in cherimoya. Romucosine H is an alkaloid from Annona cherimola (cherimoya).

Phosphatidylserine

(2S)-2-amino-3-({[(2R)-2-(butanoyloxy)-3-(propanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C13H24NO10P (385.1138)

Phosphatidylserine (PS) is a phospholipid nutrient found in fish, green leafy vegetables, soybeans and rice, and is essential for the normal functioning of neuronal cell membranes and activates Protein kinase C (PKC) which has been shown to be involved in memory function. In apoptosis, phosphatidylserine is transferred to the outer leaflet of the plasma membrane. This is part of the process by which the cell is targeted for phagocytosis. PS has been shown to slow cognitive decline in animal models. PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. Because of the potentail cognitive benefits of phosphatidylserine, the substance is sold as a dietary supplement to people who believe they can benefit from an increased intake. The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.

Nilvadipine

3-methyl 5-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

C19H19N3O6 (385.1274)

Nilvadipine is only found in individuals that have used or taken this drug. It is a calcium channel blocker (CCB) for treatment of hypertension.Nilvadipine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. The decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

(R)-N-(1-Methyl-2-phenylethyl)adenosine

2-Hydroxymethyl-5-[6-(1-methyl-2-phenyl-ethylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol

C19H23N5O4 (385.175)

D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents

2,5-Dioxopyrrolidin-1-YL 4-(pyren-1-YL)butanoate

2,5-Dioxopyrrolidin-1-yl 4-(pyren-1-yl)butanoic acid

C24H19NO4 (385.1314)

3-Desmethylcolchicine

N-{5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}ethanimidate

C21H23NO6 (385.1525)

Bifeprunox

7-{4-[(3-phenylphenyl)methyl]piperazin-1-yl}-2,3-dihydro-1,3-benzoxazol-2-one

C24H23N3O2 (385.179)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

(4As,5aS,6S,12aS)-1,6,10,11-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide

C20H19NO7 (385.1161)

(4As,5aR,6R,12aR)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

C20H19NO7 (385.1161)

Colchiceine

N-{14-hydroxy-3,4,5-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}acetamide

C21H23NO6 (385.1525)

Ecadotril

benzyl 2-{2-[(acetylsulfanyl)methyl]-3-phenylpropanamido}acetate

C21H23NO4S (385.1348)

Fleroxacin N-oxide

4-[3-carboxy-6,8-difluoro-1-(2-fluoroethyl)-4-oxo-1,4-dihydroquinolin-7-yl]-1-methylpiperazin-1-ium-1-olate

C17H18F3N3O4 (385.1249)

Isopropylphenyladenosine

2-(hydroxymethyl)-5-{6-[phenyl(propan-2-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C19H23N5O4 (385.175)

Minoxidil Glucuronide

6-{[6-amino-2-imino-4-(piperidin-1-yl)-1,2-dihydropyrimidin-1-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H23N5O7 (385.1597)

n6-phenylisopropyladenosine

5-(hydroxymethyl)-2-[6-(phenylamino)-9H-purin-9-yl]-2-(propan-2-yl)oxolane-3,4-diol

C19H23N5O4 (385.175)

PURPUREINE

C22H27NO5 (385.1889)

3-Demethylcolchicine

C21H23NO6 (385.1525)

3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2]. 3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2].

2-Demethylcolchicine

(-)-2-Demethylcolchicine

C21H23NO6 (385.1525)

Delnuttaline

C22H27NO5 (385.1889)

Muramine

C22H27NO5 (385.1889)

A dibenzazecine alkaloid that is 5,7,8,14-tetrahydrodibenzo[c,g]azecin-13(6H)-one substituted by a methyl group at position 6 and by methoxy groups at positions 3, 4, 10, and 11.

O-Methylthaicanine

(-)-O-Methylthaicanine

C22H27NO5 (385.1889)

31F508b1

Antibiotic 31F508b1

C20H23N3O5 (385.1638)

Szovitsamine

C22H27NO5 (385.1889)

Geyeridine

6-Hydroxy-13-O-acetylhetisinone

C22H27NO5 (385.1889)

Asparagamine A

Didehydrostemofoline

C22H27NO5 (385.1889)

canadinic acid

C21H23NO6 (385.1525)

N-Methylporphyroxine

11,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0^{2,10}.0^{5,9}.0^{14,19}]docosa-2,4,9,14(19),15,17-hexaen-16-ol

C21H23NO6 (385.1525)

4-Hydroxycanadaline

C21H23NO6 (385.1525)

N-Methoxycarbonyllaurotetanine

C21H23NO6 (385.1525)

Amisulpride N-Oxide

C17H27N3O5S (385.1671)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 3399 CONFIDENCE standard compound; INTERNAL_ID 2143

MAM-2201 N-pentanoic acid metabolite

C25H23NO3 (385.1678)

JWH-098

C26H27NO2 (385.2042)

(5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

C26H24FNO (385.1842)

ZINC299817322

C26H24FNO (385.1842)

(5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

C26H24FNO (385.1842)

Racecadotril

Racecadotril (Acetorphan)

C21H23NO4S (385.1348)

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

CHEMBL1560835

C22H27NO5 (385.1889)

MMV020591

C24H23N3O2 (385.179)

CHEMBL531095

C21H18F3N3O (385.1402)

Anthocyanin 3-O-beta-D-glucoside

C21H21O7+ (385.1287)

(13S,14R)-1,13-dihydroxy-N-methylcanadine

C21H23NO6 (385.1525)

C20H19NO7

C20H19NO7 (385.1161)

fumarofine

C20H19NO7 (385.1161)

5-Benzyl-N-Dimethyladenosine

C19H23N5O4 (385.175)

N2-(N2-L-Pyroglutamyl-L-glutaminyl)-L-glutamin|N2-(N2-L-pyroglutamyl-L-glutaminyl)-L-glutamine

C15H23N5O7 (385.1597)

MLS001202244

C21H23NO6 (385.1525)

NSC180539

C21H23NO6 (385.1525)

??-Hydrastine

C21H23NO6 (385.1525)

C21H23NO6

C21H23NO6 (385.1525)

Colchicine, O(3)-demethyl-

C21H23NO6 (385.1525)

NEOLAMELLARIN A

C24H19NO4 (385.1314)

O(sup 2)-Demethylcolchicine

C21H23NO6 (385.1525)

(7bR)-7t-Acetylamino-2-hydroxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]-cyclobuta[1,2-c]cyclohepten-8-on|(7bR)-7t-acetylamino-2-hydroxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]-cyclobuta[1,2-c]cyclohepten-8-one|O2-De-Me-beta-Lumicolchicine

(7bR)-7t-Acetylamino-2-hydroxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]-cyclobuta[1,2-c]cyclohepten-8-on|(7bR)-7t-acetylamino-2-hydroxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]-cyclobuta[1,2-c]cyclohepten-8-one|O2-De-Me-beta-Lumicolchicine

C21H23NO6 (385.1525)

5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid

5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid

C20H19NO7 (385.1161)

methyl 7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside

C14H27NO11 (385.1584)

59654-07-8

C21H23NO6 (385.1525)

C22H27NO5

C22H27NO5 (385.1889)

intebrine

C20H19NO7 (385.1161)

guan-fu base Q

C22H27NO5 (385.1889)

(5RS)-3-methyl-5-{(1SR,2SR,3aRS,10bRS)-1-methyl-8-[(2SR,4SR)-4-methyl-5-oxotetrahydrofuran-2-yl]-1,3a,4,5,6,10b-hexahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-yl}furan-2(5H)-one|bisdehydrostemocochinine

(5RS)-3-methyl-5-{(1SR,2SR,3aRS,10bRS)-1-methyl-8-[(2SR,4SR)-4-methyl-5-oxotetrahydrofuran-2-yl]-1,3a,4,5,6,10b-hexahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-yl}furan-2(5H)-one|bisdehydrostemocochinine

C22H27NO5 (385.1889)

(+/-)-emiline

C21H23NO6 (385.1525)

(+-)-aryapavine|11-hydroxy-12-hydroxymethyl-1,10-dimethoxy-2,3-methylenedioxyberbine|12-hydroxymethyl-10,14-dimethoxy-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-11-ol|12-Hydroxymethylprotoberberin|Aryapavin|Aryapavine

C21H23NO6 (385.1525)

O-Butyl (E)-[4-(alpha-L-rhamnosyloxy)benzyl]thiocarbamate|O-butyl 4-[(alpha-L-rhamnosyloxy)benzyl]thiocarbamate

C18H27NO6S (385.1559)

Ianthellidone C

C20H19NO7 (385.1161)

SCHEMBL11903389

C20H36BrNO (385.198)

(+)-N-(methoxycarbonyl)-N-norpredicentrine

C21H23NO6 (385.1525)

(S)-7-Dimethylamino-1,2,3,10-tetramethoxy-6,7-dihydro-5H-benzo[a]heptalen-9-on|(S)-7-dimethylamino-1,2,3,10-tetramethoxy-6,7-dihydro-5H-benzo[a]heptalen-9-one|N,N-Dimethyl-desacetyl-colchicin|N,N-dimethyldeacetylcolchicine|N-Methyl-demecolcin|N-methyldemecolcine|N-Methyldemecolcine.|N-methyldemocolcine

C22H27NO5 (385.1889)

2-Desmethyl-beta-lumicolchicin|O2-Demethyl-beta-lumicolchicin|O3-De-Me-beta-Lumicolchicine

C21H23NO6 (385.1525)

Cinereapyrrole A

C23H19N3O3 (385.1426)

(+)-N-(methoxy-carbonyl)-N-norlauroscholtzine

C21H23NO6 (385.1525)

(+)-triniifoline

C21H23NO6 (385.1525)

2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-D-galactitol|2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactitol|beta-D-Gal-(1->3)-D-GalNAcol|beta-D-Galp(1->3)-D-GalNAc-ol|beta-Gal-(1-3)-GalNAc-ol

2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-D-galactitol|2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactitol|beta-D-Gal-(1->3)-D-GalNAcol|beta-D-Galp(1->3)-D-GalNAc-ol|beta-Gal-(1-3)-GalNAc-ol

C14H27NO11 (385.1584)

(-)-8-oxo-11-hydroxy-2,3,9,10-tetramethoxyberberine

C21H23NO6 (385.1525)

Androcimine

C22H27NO5 (385.1889)

Tunichrome Mm-1|Tunichrome Mm1

C19H19N3O6 (385.1274)

fumaritridine

C21H23NO6 (385.1525)

(+)-chelamidine|chelamidine

C21H23NO6 (385.1525)

(S)-4,9,10,11-tetramethoxy-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinoline|Nor-Leucoxylonin|Norleucoxylonine

C21H23NO6 (385.1525)

Buntanmine A|buntanmine-A

C21H23NO6 (385.1525)

(+)-ocoxylonine|(S)-4,10,11-trimethoxy-7-methyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-9-ol|Ocoxylonin|Ocoxylonine

C21H23NO6 (385.1525)

C21H27N3O2S

C21H27N3O2S (385.1824)

Met His Val

C16H27N5O4S (385.1784)

His Glu Thr

C15H23N5O7 (385.1597)

Phe Tyr Gly

C20H23N3O5 (385.1638)

His Cys Leu

C16H27N5O4S (385.1784)

Val Met His

C16H27N5O4S (385.1784)

Leu Cys His

C16H27N5O4S (385.1784)

His Leu Cys

C16H27N5O4S (385.1784)

DTXSID50875240

C20H23N3O5 (385.1638)

H-GLY-PHE-TYR-OH

C20H23N3O5 (385.1638)

DTXSID101017821

C26H27NO2 (385.2042)

Cys Tyr Thr

C16H23N3O6S (385.1307)

His Thr Glu

C15H23N5O7 (385.1597)

Met Val His

C16H27N5O4S (385.1784)

Cys Thr Tyr

C16H23N3O6S (385.1307)

Cys His Leu

C16H27N5O4S (385.1784)

DTXSID401017820

C26H27NO2 (385.2042)

His Asp Asp

C14H19N5O8 (385.1234)

Phe Gly Tyr

C20H23N3O5 (385.1638)

ACMC-20mm8d

C20H23N3O5 (385.1638)

Thr Glu His

C15H23N5O7 (385.1597)

Asp Asp His

C14H19N5O8 (385.1234)

Glu Thr His

C15H23N5O7 (385.1597)

His Val Met

C16H27N5O4S (385.1784)

Cys Leu His

C16H27N5O4S (385.1784)

Gly Tyr Phe

C20H23N3O5 (385.1638)

Tyr Cys Thr

C16H23N3O6S (385.1307)

His Met Val

C16H27N5O4S (385.1784)

Thr His Glu

C15H23N5O7 (385.1597)

Val His Met

C16H27N5O4S (385.1784)

(-)-N-Methylthaicanine

C22H27NO5 (385.1889)

cis-N-Methylcapaurine

C22H27NO5 (385.1889)

6-hydroxy-allocryptopine

C21H23NO6 (385.1525)

NCI60_001400

N-[(7S,12aRa)-3-Hydroxy-1,2,10-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide (3-O-Demethylcolchicine)

C21H23NO6 (385.1525)

3-Desmethylcolchicine is a natural product found in Colchicum arenarium, Colchicum bivonae, and other organisms with data available. 3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2]. 3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2].

Sarafloxacin

C20H17F2N3O3 (385.1238)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3620 EAWAG_UCHEM_ID 3620; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1035

(1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-3-yl)methanol

C22H27NO5 (385.1889)

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.682 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.677

Nilvadipine (ARC029)

C19H19N3O6 (385.1274)

Conchacarpine B

C23H19N3O3 (385.1426)

Fontanesine A

C23H19N3O3 (385.1426)

Fontanesine C

C23H19N3O3 (385.1426)

MMV023388

C21H18N3OF3 (385.1402)

Ala Ala Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C16H27N5O6 (385.1961)

Ala Ala Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Ala Pro Ala Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-carbamoylbutanoic acid

C16H27N5O6 (385.1961)

Ala Pro Gln Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]propanoic acid

C16H27N5O6 (385.1961)

Ala Gln Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Ala Gln Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H27N5O6 (385.1961)

minoxidil glucuronide

Minoxidil-O-glucuronide

C15H23N5O7 (385.1597)

Gly Asn Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C16H27N5O6 (385.1961)

Gly Asn Val Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Gly Pro Asn Val

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylbutanoic acid

C16H27N5O6 (385.1961)

Gly Pro Val Asn

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-carbamoylpropanoic acid

C16H27N5O6 (385.1961)

Gly Val Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Gly Val Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C16H27N5O6 (385.1961)

His Val Met

C16H27N5O4S1 (385.1784)

Val Met His

C16H27N5O4S1 (385.1784)

Val His Met

C16H27N5O4S1 (385.1784)

Glu His Thr

C15H23N5O7 (385.1597)

Tyr Gly Phe

C20H23N3O5 (385.1638)

3-Piperidinemethanol, 4-(4-fluorophenyl)-, (3S,4R)-glucuronide

C18H24FNO7 (385.1537)

Cys Tyr Thr

C16H23N3O6S1 (385.1307)

Thr Cys Tyr

C16H23N3O6S1 (385.1307)

Met Val His

C16H27N5O4S1 (385.1784)

Met His Val

C16H27N5O4S1 (385.1784)

Desmethylcolchicine

C21H23NO6 (385.1525)

His Met Val

C16H27N5O4S1 (385.1784)

Asn Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C16H27N5O6 (385.1961)

Asn Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Asn Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C16H27N5O6 (385.1961)

Asn Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C16H27N5O6 (385.1961)

Asn Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Asn Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H27N5O6 (385.1961)

Pro Ala Ala Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

C16H27N5O6 (385.1961)

Pro Ala Gln Ala

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]propanoic acid

C16H27N5O6 (385.1961)

Pro Gly Asn Val

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-methylbutanoic acid

C16H27N5O6 (385.1961)

Pro Gly Val Asn

(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]propanoic acid

C16H27N5O6 (385.1961)

Pro Asn Gly Val

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-methylbutanoic acid

C16H27N5O6 (385.1961)

Pro Asn Val Gly

2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]acetic acid

C16H27N5O6 (385.1961)

Pro Gln Ala Ala

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

C16H27N5O6 (385.1961)

Pro Val Gly Asn

(2S)-3-carbamoyl-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}propanoic acid

C16H27N5O6 (385.1961)

Pro Val Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]acetic acid

C16H27N5O6 (385.1961)

Gln Ala Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Gln Ala Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H27N5O6 (385.1961)

Gln Pro Ala Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C16H27N5O6 (385.1961)

Tyr Phe Gly

C20H23N3O5 (385.1638)

Tyr Cys Thr

C16H23N3O6S1 (385.1307)

Tyr Thr Cys

C16H23N3O6S1 (385.1307)

Thr Tyr Cys

C16H23N3O6S1 (385.1307)

Gly Phe Tyr

C20H23N3O5 (385.1638)

Asp His Asp

C14H19N5O8 (385.1234)

Cys Thr Tyr

C16H23N3O6S1 (385.1307)

Val Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Val Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C16H27N5O6 (385.1961)

Val Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H27N5O6 (385.1961)

Val Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H27N5O6 (385.1961)

Val Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

C16H27N5O6 (385.1961)

Val Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

C16H27N5O6 (385.1961)

Colchiceine

C21H23NO6 (385.1525)

(2S)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)

Lys-Met-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C16H23N3O6S (385.1307)

Met-Lys-OH

(S)-7-amino-2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)heptanoic acid

C16H23N3O6S (385.1307)

JWH098

C26H27NO2 (385.2042)

JWH 210 N-(5-hydroxypentyl)

C26H27NO2 (385.2042)

JWH 307

C26H24FNO (385.1842)

JWH 368

C26H24FNO (385.1842)

Nilvadipine

3-methyl 5-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

C19H19N3O6 (385.1274)

C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

Glaucamine

16,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0^{2,10}.0^{5,9}.0^{14,19}]docosa-2,4,9,14(19),15,17-hexaen-11-ol

C21H23NO6 (385.1525)

Papaverrubine B

11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0^{2,10}.0^{5,9}.0^{14,19}]docosa-2,4,9,14,16,18-hexaene

C21H23NO6 (385.1525)

Thalicpureine

2,3,4,6,7-Pentamethoxy-N-methyl-1-phenanthrenemethanamine, 9ci

C22H27NO5 (385.1889)

A phenanthrene substituted by a 2-(methylamino)ethyl group at position 1 and by methoxy groups at positions 2,3,4,6 and 7, respectively. It is a plant metabolite isolated from Annona purpurea and Fagonia olivieri.

Romucosine H

methyl 3-hydroxy-4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,13(17),14-hexaene-10-carboxylate

C21H23NO6 (385.1525)

JWH 210 N-(4-hydroxypentyl) metabolite

C26H27NO2 (385.2042)

CEHC taurine

N-(5-[(2R)-6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]-propanoyl)-taurine

C18H27NO6S (385.1559)

(S)-4-(4-(BENZYLOXY)PHENYL)-3-((TERT-BUTOXYCARBONYL)AMINO)BUTANOIC ACID

C22H27NO5 (385.1889)

N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide

C18H19N5O5 (385.1386)

(R)?-?PIA

(R)-N-(1-Methyl-2-phenylethyl)adenosine

C19H23N5O4 (385.175)

D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents

JWH-307

C26H24FNO (385.1842)

2,6-dimethyl-4-(3-nitrophenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylic acid 2-cyanoethyl ester

C19H19N3O6 (385.1274)

Dexecadotril

C21H23NO4S (385.1348)

BOC-(3S,4S)-4-AMINO-3-HYDROXY-5-(4-PHENYL)PHENYLPENTANOICACID

C22H27NO5 (385.1889)

Ecadotril

C21H23NO4S (385.1348)

D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

Fmoc-L-β-homomethionine

C21H23NO4S (385.1348)

Suc-Phe-pNA

C19H19N3O6 (385.1274)

(+)-(5aR,10bS)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Chloride Monohydrate

C21H24ClN3O2 (385.1557)

(2S,4R)-1-(tert-butoxycarbonyl)-4-(tosyloxy)pyrrolidine-2-carboxylic acid

C17H23NO7S (385.1195)

fast black salt G

C21H19N7O++ (385.1651)

Amsilarotene

C20H27NO3Si2 (385.1529)

2-(6,7-DIMETHOXY-3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YLMETHYLSULFANYL)-BENZOIC ACID

C21H23NO4S (385.1348)

Fmoc n-me-l-met-oh

C21H23NO4S (385.1348)

L-ASPARTIC ACID BIS-ALLYL ESTER P-TOLUENESULFONATE SALT

C17H23NO7S (385.1195)

(5-(4-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

C26H24FNO (385.1842)

(R,S)-FMOC-1,3-DIHYDRO-2H-ISOINDOLE CARBOXYLIC ACID

C24H19NO4 (385.1314)

N,N-BIS(DIPHENYLPHOSPHINO)AMINE

C24H21NP2 (385.1149)

Boc-N-methyl-O-benzyl-L-tyrosine

C22H27NO5 (385.1889)

Denibulin

methyl N-[6-[4-[[(2S)-2-aminopropanoyl]amino]phenyl]sulfanyl-1H-benzimidazol-2-yl]carbamate

C18H19N5O3S (385.1209)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

2-[ethyl[3-methyl-4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]amino]ethanol

C18H19N5O3S (385.1209)

N-Hydroxysuccinimidyl Pyrenebutanoate

2,5-Dioxopyrrolidin-1-YL 4-(pyren-1-YL)butanoate

C24H19NO4 (385.1314)

Valethamate Bromide

C19H32BrNO2 (385.1616)

Capecitabine-2,3-cyclic Carbonate

C16H20FN3O7 (385.1285)

(4R,5S)-1-BENZYL-4-(4-FLUORO-PHENYL)-5-HYDROXYMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID TERT-BUTYL ESTER

C23H28FNO3 (385.2053)

2-METHOXY-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE

C19H19N3O6 (385.1274)

(E)-4-Methyl-N-(2-oxo-1-phenyl-2-(piperidin-1-yl)ethylidene)benzenesulfonohydrazide

C20H23N3O3S (385.146)

2-(7-Methoxy-1-naphthyl)-N-[2-(7-methoxy-1-naphthyl)ethyl]ethanamine

C26H27NO2 (385.2042)

FMOC-L-INDOLINE-2-CARBOXYLIC ACID

C24H19NO4 (385.1314)

Acumapimod

C22H19N5O2 (385.1539)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine

C26H27NO2 (385.2042)

2-Demethyl Colchicine-d3

C21H23NO6 (385.1525)

CEPHRADINE (200 MG)

C16H23N3O6S (385.1307)

(-)-O,O-DIBENZOYL-L-TARTARIC ACID MONO(DIMETHYLAMIDE)

C20H19NO7 (385.1161)

1-(2,4-dimethylbenzyl)-6-(1-methyl-1H-pyrrol-2-yl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile

C21H18F3N3O (385.1402)

5-[(2S,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-2,2,5-trimethyl-1,3-dioxane-4,6-dione

C18H31NO6Si (385.1921)

Ciprofloxacin Hydrochloride

Ciprofloxacin Hydrochloride hydrate

C17H21ClFN3O4 (385.1205)

D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and induces apoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].

Fmoc-8-amino-3,6-dioxaoctanoic acid

C21H23NO6 (385.1525)

2,2,2-TRIFLUORO-1-(4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZIN-1-YL)ETHANONE

C17H23BF3N3O3 (385.1784)

3-{isopropyl[(Trans-4-Methylcyclohexyl)carbonyl]amino}-5-Phenylthiophene-2-Carboxylic Acid

C22H27NO3S (385.1712)

D-Phenylalanyl-N-(3-Chlorobenzyl)-L-Prolinamide

C21H24ClN3O2 (385.1557)

6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylic acid

C17H18F3N3O4 (385.1249)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

Momfluorothrin, (Z,1R,3R)-

C19H19F4NO3 (385.1301)

2-Acetamido-2-deoxyglucosylgalactitol

C14H27NO11 (385.1584)

2-phenyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-4-quinolinecarboxamide

C23H19N3OS (385.1249)

4-[[[4-(9H-fluoren-9-yl)-1-piperazinyl]amino]methylidene]-3-hydroxy-1-cyclohexa-2,5-dienone

C24H23N3O2 (385.179)

1-[4-(2-pyridinyl)-1-piperazinyl]-2-(9H-xanthen-9-yl)ethanone

C24H23N3O2 (385.179)

N-[2-[1-(4-fluoro-2-methylphenyl)sulfonyl-2-piperidinyl]ethyl]-N-methyloxamide

C17H24FN3O4S (385.1471)

N2-[(1S,2R)-2-aminocyclohexyl]-N6-(3-chlorophenyl)-9-ethylpurine-2,6-diamine

C19H24ClN7 (385.1782)

7-Acetamido-10-hydroxy-1,2,3-trimethoxy-6,7-dihydrobenzo[a]heptalen-9(5H)-one

C21H23NO6 (385.1525)

4-((3R,4S,5R)-4-Amino-3,5-dihydroxy-hex-1-ynyl)-5-fluoro-3-[1-(3-methoxy-1H-pyrrol-2-YL)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one

C20H20FN3O4 (385.1438)

3(S)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester

C16H23N3O6S (385.1307)

3(R)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester

C16H23N3O6S (385.1307)

(4as)-5-[(2,4-Diaminopteridin-6-Yl)methyl]-4a,5-Dihydro-2h-Dibenzo[b,F]azepin-8-Ol

C21H19N7O (385.1651)

[N-(3-Dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid

C20H23N3O5 (385.1638)

Bifeprunox

C24H23N3O2 (385.179)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Prifinium Bromide

C22H28BrN (385.1405)

Phosphatidyl-L-serine

(2S)-2-amino-3-[hydroxy-[(2R)-2-(1-oxobutoxy)-3-(1-oxopropoxy)propoxy]phosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)

[4,5-Dihydroxy-6-[4-[(methoxycarbothioylamino)methyl]phenoxy]-2-methyloxan-3-yl] acetate

C17H23NO7S (385.1195)

(2R)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)

(+)-7-iso-12COOH-JA-Phe

C21H23NO6-2 (385.1525)

3-[(2Z,4Z)-5-carbamoyl-3-(dimethylamino)-4-hydroxypenta-2,4-dien-1-yl]-1,8-dihydroxy-4-methylnaphthalene-2-carboxylate

C20H21N2O6- (385.14)

3-ethoxy-N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide

C23H19N3O3 (385.1426)

N-[3-(1,3-benzothiazol-2-yl)-7-propan-2-yl-4,5,6,8-tetrahydrothieno[2,3-c]azepin-2-yl]acetamide

C20H23N3OS2 (385.1282)

N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-4,5,7,8-tetrahydrothieno[2,3-d]azepin-2-yl]acetamide

C20H23N3OS2 (385.1282)

1,2-Didehyrostemofoline

C22H27NO5 (385.1889)

(7S)-7-acetamido-1,2,3-trimethoxy-6,7-dihydro-5H-dibenzo[5,3-b:1,2-e][7]annulene-9-carboxylic acid

C21H23NO6 (385.1525)

Gly-Tyr-Phe

C20H23N3O5 (385.1638)

N-[1-(cyclopentylamino)-2-methyl-1-oxobutan-2-yl]-N-(thiophen-2-ylmethyl)-2-pyridinecarboxamide

C21H27N3O2S (385.1824)

5-[(4-Methyl-1-piperidinyl)methyl]-1-[4-(1-pyrrolyl)-1,2,5-oxadiazol-3-yl]-4-triazolecarboxylic acid ethyl ester

C18H23N7O3 (385.1862)

1-[1-[2-(4-Methoxyphenyl)ethyl]-2,5-dimethyl-3-pyrrolyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanone

C19H23N5O2S (385.1572)

4-[[3-[[(4-Nitrophenyl)-oxomethyl]amino]-1-oxopropyl]amino]benzoic acid ethyl ester

C19H19N3O6 (385.1274)

2-[4-(Cyclohexylamino)-3-nitrophenyl]-5-methyl-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione

C21H27N3O4 (385.2001)

3-(2-furanylmethyl)-4-oxo-N,N-dipropyl-2-sulfanylidene-1H-quinazoline-7-carboxamide

C20H23N3O3S (385.146)

1-benzyl-2-methyl-3-{(E)-[2-(5-nitropyridin-2-yl)hydrazinylidene]methyl}-1H-indole

C22H19N5O2 (385.1539)

2-amino-7-hydroxy-4,4,6-trimethyl-2-oxo-4H-spiro[chromene-4,1-pyrrolo[3,2,1-ij]quinoline]-3-carbonitrile

C23H19N3O3 (385.1426)

3-[(2-Adamantylamino)-oxomethyl]-1-methylsulfonyl-1-pentylurea

C18H31N3O4S (385.2035)

3,4-dimethoxy-N-[[4-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]benzamide

C20H23N3O3S (385.146)

{3-(3-chlorobenzyl)-1-[(2E)-3-(2-methoxyphenyl)prop-2-en-1-yl]piperidin-3-yl}methanol

C23H28ClNO2 (385.1808)

N-(4-chlorophenyl)-N-ethyl-6-(propan-2-ylamino)-4-(trifluoromethyl)-3-pyridinecarboxamide

C18H19ClF3N3O (385.1169)

{3-(3-chlorobenzyl)-1-[(2E)-3-(4-methoxyphenyl)prop-2-en-1-yl]piperidin-3-yl}methanol

C23H28ClNO2 (385.1808)

4-methyl-2-[3-methyl-4-(3-methylphenyl)azo-5-oxo-4H-pyrazol-1-yl]-5-thiazolecarboxylic acid ethyl ester

C18H19N5O3S (385.1209)

N-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-4-quinazolinamine

C23H19N3O3 (385.1426)

Galbeta1-3GalNAc-ol

C14H27NO11 (385.1584)

Tyr-gly-phe

C20H23N3O5 (385.1638)

Asp-His-Asp

C14H19N5O8 (385.1234)

Thr-His-Glu

C15H23N5O7 (385.1597)

Phe-Gly-Tyr

C20H23N3O5 (385.1638)

Tyr-Phe-Gly

C20H23N3O5 (385.1638)

Asp-Asp-His

C14H19N5O8 (385.1234)

Met-Val-His

C16H27N5O4S (385.1784)

Phe-Tyr-Gly

C20H23N3O5 (385.1638)

Tyr-Cys-Thr

C16H23N3O6S (385.1307)

(3R,6R,14aR,14bR)-3-[(1R)-1-chloroethyl]-3,6-dihydroxy-6-methyl-5-methylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione

C18H24ClNO6 (385.1292)

(5Z)-5-[(1S,4S,5R,6S,8S,9S,13S)-9-[(E)-but-1-enyl]-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.01,5.06,10.09,13]tetradecan-3-ylidene]-4-methoxy-3-methylfuran-2-one

C22H27NO5 (385.1889)

Galbeta1-4GlcNAc-ol

C14H27NO11 (385.1584)

1-[4-[4-(4-Methyl-1-piperazinyl)phenyl]-2-thiazolyl]-4-piperidinecarboxamide

C20H27N5OS (385.1936)

1-[(1R)-2-acetyl-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone

C21H27N3O4 (385.2001)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)

N-[(2R,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)

N-[(2R,3R,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)

[(3aS,4R,9bS)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-pyridin-4-ylmethanone

C24H23N3O2 (385.179)

(1R,5S)-3-(1,3-benzodioxol-5-ylmethyl)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane

C24H23N3O2 (385.179)

2-(dimethylamino)-1-[(2S,3S)-2-(hydroxymethyl)-3-phenyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C19H26F3N3O2 (385.1977)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)

N-[(2S,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)

N-[(2S,3S,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)

N-[(2S,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)

N-[(2R,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)

[(3aR,4S,9bR)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-pyridin-4-ylmethanone

C24H23N3O2 (385.179)

[(3aS,4S,9bS)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-pyridin-4-ylmethanone

C24H23N3O2 (385.179)

[(3aR,4R,9bR)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-pyridin-4-ylmethanone

C24H23N3O2 (385.179)

[(1R,5S)-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-pyridin-4-ylmethanone

C24H23N3O2 (385.179)

(1S,5R)-6-(1,3-benzodioxol-5-ylmethyl)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane

C24H23N3O2 (385.179)

(2S,3R)-2-(hydroxymethyl)-3-phenyl-N-propyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptane-1-carboxamide

C19H26F3N3O2 (385.1977)

(2R,3R)-2-(hydroxymethyl)-3-phenyl-N-propyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptane-1-carboxamide

C19H26F3N3O2 (385.1977)

1-[(1S)-2-acetyl-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone

C21H27N3O4 (385.2001)

(2S,3R)-2-(hydroxymethyl)-3-phenyl-N-propan-2-yl-1-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptane-6-carboxamide

C19H26F3N3O2 (385.1977)

(2S,3S)-2-(hydroxymethyl)-3-phenyl-N-propan-2-yl-1-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptane-6-carboxamide

C19H26F3N3O2 (385.1977)

(2R,3R)-2-(hydroxymethyl)-3-phenyl-N-propan-2-yl-1-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptane-6-carboxamide

C19H26F3N3O2 (385.1977)

2-(dimethylamino)-1-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C19H26F3N3O2 (385.1977)

2-(dimethylamino)-1-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C19H26F3N3O2 (385.1977)

2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-glucitol

C14H27NO11 (385.1584)

jacoline N-oxide

C18H27NO8 (385.1737)

A pyrrolizine alkaloid that is jacoline in which the tertiary amino function has been oxidised to the corresponding N-oxide.

His-Glu-Thr

C15H23N5O7 (385.1597)

Met-His-Val

C16H27N5O4S (385.1784)

Thr-Cys-Tyr

C16H23N3O6S (385.1307)

Thr-Glu-His

C15H23N5O7 (385.1597)

Tyr-Thr-Cys

C16H23N3O6S (385.1307)

His-Val-Met

C16H27N5O4S (385.1784)

Cys-Thr-Tyr

C16H23N3O6S (385.1307)

Cys-Tyr-Thr

C16H23N3O6S (385.1307)

Glu-His-Thr

C15H23N5O7 (385.1597)

Glu-Thr-His

C15H23N5O7 (385.1597)

His-Asp-Asp

C14H19N5O8 (385.1234)

His-Met-Val

C16H27N5O4S (385.1784)

His-Thr-Glu

C15H23N5O7 (385.1597)

Thr-Tyr-Cys

C16H23N3O6S (385.1307)

Val-His-Met

C16H27N5O4S (385.1784)

Val-Met-His

C16H27N5O4S (385.1784)

3-ethyl-2-[7-(3-ethyl-1,3-benzoxazol-2(3H)-ylidene)hepta-1,3,5-trien-1-yl]-1,3-benzoxazol-3-ium

C25H25N2O2+ (385.1916)

3-(beta-D-Glucopyranosyloxy)-2-phenyl-1-benzopyrylium

C21H21O7+ (385.1287)

2-[(1E,3E,5E)-7-[3-Ethylbenzoxazole-2(3H)-ylidene]-1,3,5-heptatrienyl]-3-ethylbenzoxazole-3-ium

C25H25N2O2+ (385.1916)

2-aminoethyl 4-O-beta-D-glucopyranosyl-alpha-D-glucopyranoside

C14H27NO11 (385.1584)

Galalpha1-3GalNAc-ol

C14H27NO11 (385.1584)

2-acetamido-2-deoxy-3-O-D-galactopyranosyl-D-galactitol

C14H27NO11 (385.1584)

N-[(2S,3R,4R,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide

C14H27NO11 (385.1584)

N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide

C14H27NO11 (385.1584)

1-[2-(Diethylamino)ethyl]-5-pyridin-2-yl-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione

C20H23N3O3S (385.146)

2-aminoethyl 4-O-alpha-D-glucopyranosyl-alpha-D-galactopyranoside

C14H27NO11 (385.1584)

N-[(3S)-1-quinolin-4-ylpyrrolidin-3-yl]-3-(trifluoromethyl)benzamide

C21H18F3N3O (385.1402)

2-Amino-3-[(2-butanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)

(2S)-N-(3-cyanophenyl)-3-methyl-2-[(2-naphthalen-1-ylacetyl)amino]butanamide

C24H23N3O2 (385.179)

2-Amino-3-[hydroxy-(2-hydroxy-3-octanoyloxypropoxy)phosphoryl]oxypropanoic acid

C14H28NO9P (385.1502)

Lnaps 5:0/N-2:0

C13H24NO10P (385.1138)

TEPOXALIN

C20H20ClN3O3 (385.1193)

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide

C16H23N3O8 (385.1485)

(1Z)-1-[(2-hydroxy-3,4-dimethoxyphenyl)methylidene]-6,7-dimethoxy-3,4-dihydroisoquinoline-2-carbaldehyde

C21H23NO6 (385.1525)

NNAL-N-glucuronide

C16H23N3O8 (385.1485)

nocardicin G zwitterion

C19H19N3O6 (385.1274)

An amino acid zwitterion resulting from a transfer of a proton from the carboxy group to the amino group of nocardicin G; major species at pH 7.3.

Niazicin A

C17H23NO7S (385.1195)

2-Hydroxymethyl-5-[6-(1-methyl-2-phenyl-ethylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol

C19H23N5O4 (385.175)

D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents

dehydrojaconine

C18H24ClNO6 (385.1292)

A pyrrolizine alkaloid that is jacoline in which the secondary hydroxy group has been replaced by a chlorine and the 5-methyl group has been replaced by methylene.

Didehydrostemofoline

C22H27NO5 (385.1889)

A natural product found in Stemona collinsiae.

1,2-didehydrostemofoline

C22H27NO5 (385.1889)

A natural product found in Stemona curtisii.

LPE 9:1;O2

C14H28NO9P (385.1502)

Gly-Phe-Tyr

C20H23N3O5 (385.1638)

Anthocyanin 3'-O-beta-D-glucoside

C21H21O7 (385.1287)

ST 20:5;O3;Gly

C22H27NO5 (385.1889)

FR194921

C23H23N5O (385.1903)

FR194921 is a potent, selective and orally active and cross the blood-brain barrier Adenosine A1 antagonist with Ki value of 6.6, 5400 nM for A1, A2A, respectively. FR194921 shows cognitive-enhancing and anxiolytic activity[1][2].

MLS1082

C24H23N3O2 (385.179)

MLS1082 is a pyrimidone-based D1-like dopamine receptor positive allosteric modulator, with an EC50 of 123 nM for DA-stimulated G protein signaling[1].

(1r,11s,13s)-11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaene

C21H23NO6 (385.1525)

(16s,20s,23s)-17-hydroxy-13-methoxy-20,23-dimethyl-1,11,18-triazahexacyclo[10.8.2.1¹⁶,²⁰.0²,⁷.0⁸,²².0¹⁵,²¹]tricosa-2,4,6,8(22),9,11,13,15(21),17-nonaen-19-one

C23H19N3O3 (385.1426)

3,4,5,16-tetramethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaen-17-ol

C22H27NO5 (385.1889)

2,3-dimethoxy-6-({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}methyl)benzoic acid

C21H23NO6 (385.1525)

1',2'-didehydrostemofoline

C22H27NO5 (385.1889)

5-[(r)-hydroxy[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2h-1,3-benzodioxole-4-carboxylic acid

C20H19NO7 (385.1161)

(e,2e)-3-(7-methoxy-1-methylindol-3-yl)-n-[(1e)-2-(1-methylindol-3-yl)ethenyl]prop-2-enimidic acid

C24H23N3O2 (385.179)

(12bs)-2-hydroxy-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one

C21H23NO6 (385.1525)

5-[(1r,3e,4r,5s,6r,8r,9r,13s)-9-[(1e)-but-1-en-1-yl]-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.0¹,⁵.0⁶,¹⁰.0⁹,¹³]tetradecan-3-ylidene]-4-methoxy-3-methylfuran-2-one

C22H27NO5 (385.1889)

(2e)-3-(3,4-dimethoxyphenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylprop-2-enamide

C22H27NO5 (385.1889)

(1r,11r,13s)-16,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-11-ol

C21H23NO6 (385.1525)

3,4,5,17-tetramethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaen-16-ol

C22H27NO5 (385.1889)

3,4-bis(4-hydroxyphenyl)-1-(2-phenylethyl)pyrrole-2,5-dione

C24H19NO4 (385.1314)

1,4-dihydroxy-3-[(6r)-6-(hydroxymethyl)-4-methylocta-2,4-dienoyl]-5-(4-hydroxyphenyl)pyridin-2-one

C21H23NO6 (385.1525)

(10s)-10-(dimethylamino)-3,4,5,14-tetramethoxytricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-13-one

C22H27NO5 (385.1889)

(16r,20r,21s)-17-hydroxy-13-methoxy-20,21-dimethyl-1,11,18-triazahexacyclo[10.9.2.0²,⁷.0⁸,²³.0¹⁵,²².0¹⁶,²⁰]tricosa-2,4,6,8(23),9,11,13,15(22),17-nonaen-19-one

C23H19N3O3 (385.1426)

(1r,11s)-11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaene

C21H23NO6 (385.1525)

12,16-dimethoxy-21-methyl-4,6-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0³,⁷.0¹³,¹⁸]henicosa-2,7,9,13(18),14,16-hexaene-1,15-diol

C21H23NO6 (385.1525)

n-{4-hydroxy-3,5,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl}ethanimidic acid

C21H23NO6 (385.1525)

methyl 5-hydroxy-4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate

C21H23NO6 (385.1525)

β-hydrastine

C21H23NO6 (385.1525)

{"Ingredient_id": "HBIN018149","Ingredient_name": "\u03b2-hydrastine","Alias": "NA","Ingredient_formula": "C21H23NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9701","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

bisdehydrostemoninine

C22H27NO5 (385.1889)

{"Ingredient_id": "HBIN018615","Ingredient_name": "bisdehydrostemoninine","Alias": "NA","Ingredient_formula": "C22H27NO5","Ingredient_Smile": "CCC1C2C(CCCN3C2=CC=C3C4CC(C(=O)O4)C)OC15C=C(C(=O)O5)C","Ingredient_weight": "385.5 g/mol","OB_score": "38.50614129","CAS_id": "NA","SymMap_id": "SMIT10519","TCMID_id": "NA","TCMSP_id": "MOL009380","TCM_ID_id": "NA","PubChem_id": "11842856","DrugBank_id": "NA"}